Cladribine Impurity 6 | CAS 136834-39-4 - Request Quote
Cladribine Impurity 6
| SZ CAT No: | SZ-C102016 |
| CAS No | 136834-39-4 |
| Mol.F. | C10H11ClN4O4 |
| Mol.Wt. | 286.7 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cladribine Impurity 6 is chemically 2-Chloro-9-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-ol. Cladribine Impurity 6 is supplied with detailed characterization data compliant with regulatory guideline. Cladribine Impurity 6 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cladribine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 136834-39-4
Purchase 136834-39-4
Order 136834-39-4
Enquire 136834-39-4
price of 136834-39-4
136834-39-4 Supplier
136834-39-4 Manufacturer
136834-39-4 Exporter
buy high quality Cladribine Impurity 6
Purchase Cladribine Impurity 6
Cladribine Impurity 6 suppliers
Cladribine Impurity 6 manufacturers
Cladribine Impurity 6 price
Order Cladribine Impurity 6
Enquire Cladribine Impurity 6
Cladribine Impurity 6 cost
Cladribine Impurity 6 Supplier
Cladribine Impurity 6 Distributor
Cladribine Impurity 6 for Method Validation
Cladribine Reference Standard
Cladribine Impurity 6 for ANDA Filing
Cladribine Impurity 6 for Forced Degradation Studies
Cladribine Impurity 6 Identification Standards
Cladribine Impurity 6 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


